Relative Contributions of Presystemic and Systemic Peptidases to Oral Exposure of a Novel Metabotropic Glutamate 2/3 Receptor Agonist (LY404039) After Oral Administration of Prodrug Pomaglumetad Methionil (LY2140023)
Year: 2014
Type: article
DOI: 10.1002/jps.24226
Institutions: Eli Lilly (United States), Covance (United Kingdom)
Language: English
Subfield: Pharmacology
Domain: Life Sciences
Open Access status: closed
Funder: Eli Lilly and Company
OpenAlex ID: W2146759592
